• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型非增殖性黄斑毛细血管扩张症中的进行性视网膜内层神经变性。

Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2.

作者信息

Amram Alec L, Whitmore S Scott, Wang Cheryl, Clavell Christine, Lyons Lance J, Rusakevich Alexander M, Han Ian, Folk James, Boldt H Culver, Stone Edwin M, Russell Stephen R, Lee Kyungmoo, Abramoff Michael, Wykoff Charles, Sohn Elliott H

机构信息

Department of Ophthalmology & Visual Sciences, University of Iowa Health Care, Iowa City, Iowa, USA.

Retina Consultants of Houston, Houston, Texas, USA.

出版信息

Br J Ophthalmol. 2025 Feb 24;109(3):401-407. doi: 10.1136/bjo-2023-325115.

DOI:10.1136/bjo-2023-325115
PMID:39288977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11866295/
Abstract

PURPOSE

Patients with non-proliferative macular telangiectasia type 2 (MacTel) have ganglion cell layer (GCL) and nerve fibre layer (NFL) loss, but it is unclear whether the thinning is progressive. We quantified the change in retinal layer thickness over time in MacTel with and without diabetes.

METHODS

In this retrospective, multicentre, comparative case series, subjects with MacTel with at least two optical coherence tomographic (OCT) scans separated by >9 months OCTs were segmented using the Iowa Reference Algorithms. Mean NFL and GCL thickness was computed across the total area of the early treatment diabetic retinopathy study grid and for the inner temporal region to determine the rate of thinning over time. Mixed effects models were fit to each layer and region to determine retinal thinning for each sublayer over time.

RESULTS

115 patients with MacTel were included; 57 patients (50%) had diabetes and 21 (18%) had a history of carbonic anhydrase inhibitor (CAI) treatment. MacTel patients with and without diabetes had similar rates of thinning. In patients without diabetes and untreated with CAIs, the temporal parafoveal NFL thinned at a rate of -0.25±0.09 µm/year (95% CI [-0.42 to -0.09]; p=0.003). The GCL in subfield 4 thinned faster in the eyes treated with CAI (-1.23±0.21 µm/year; 95% CI [-1.64 to -0.82]) than in untreated eyes (-0.19±0.16; 95% CI [-0.50, 0.11]; p<0.001), an effect also seen for the inner nuclear layer. Progressive outer retinal thinning was observed.

CONCLUSIONS

Patients with MacTel sustain progressive inner retinal neurodegeneration similar to those with diabetes without diabetic retinopathy. Further research is needed to understand the consequences of retinal thinning in MacTel.

摘要

目的

2型非增殖性黄斑毛细血管扩张症(MacTel)患者存在神经节细胞层(GCL)和神经纤维层(NFL)变薄,但尚不清楚这种变薄是否会进展。我们对患有和未患有糖尿病的MacTel患者视网膜层厚度随时间的变化进行了量化。

方法

在这项回顾性、多中心、比较性病例系列研究中,对具有至少两次间隔超过9个月的光学相干断层扫描(OCT)的MacTel患者,使用爱荷华参考算法对OCT图像进行分层。计算早期治疗糖尿病性视网膜病变研究网格总面积以及颞侧内部区域的平均NFL和GCL厚度,以确定随时间的变薄速率。对每一层和区域拟合混合效应模型,以确定每个子层随时间的视网膜变薄情况。

结果

纳入115例MacTel患者;57例(50%)患有糖尿病,21例(18%)有碳酸酐酶抑制剂(CAI)治疗史。患有和未患有糖尿病的MacTel患者变薄速率相似。在未患有糖尿病且未接受CAI治疗的患者中,颞侧旁黄斑NFL以-0.25±0.09 µm/年的速率变薄(95%置信区间[-0.42至-0.09];p = 0.003)。在接受CAI治疗的眼中,4区的GCL变薄速度更快(-1.23±0.21 µm/年;95%置信区间[-1.64至-0.82]),高于未治疗的眼(-0.19±0.16;95%置信区间[-0.50, 0.11];p < 0.001),内核层也观察到这种效应。观察到视网膜外层逐渐变薄。

结论

MacTel患者存在与无糖尿病视网膜病变的糖尿病患者相似的进行性视网膜内层神经退行性变。需要进一步研究以了解MacTel患者视网膜变薄的后果。

相似文献

1
Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2.2型非增殖性黄斑毛细血管扩张症中的进行性视网膜内层神经变性。
Br J Ophthalmol. 2025 Feb 24;109(3):401-407. doi: 10.1136/bjo-2023-325115.
2
Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A.2A型非增殖性特发性黄斑毛细血管扩张症患者眼睛中视网膜神经节细胞变薄。
Invest Ophthalmol Vis Sci. 2015 Feb 5;56(2):1416-22. doi: 10.1167/iovs.14-15672.
3
Retinal neurodegeneration in eyes with NPDR risk phenotypes: A two-year longitudinal study.伴有 NPDR 风险表型的眼中的视网膜神经退行性变:一项为期两年的纵向研究。
Acta Ophthalmol. 2024 Jun;102(4):e539-e547. doi: 10.1111/aos.15787. Epub 2023 Oct 5.
4
Correlation between corneal and retinal neurodegenerative changes and their association with microvascular perfusion in type II diabetes.II 型糖尿病患者角膜和视网膜神经退行性变的相关性及其与微血管灌注的关系。
Acta Ophthalmol. 2019 Jun;97(4):e545-e550. doi: 10.1111/aos.13938. Epub 2018 Oct 11.
5
Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.黄斑毛细血管扩张症分期:功率多普勒光相干断层扫描和黄斑色素密度。
Invest Ophthalmol Vis Sci. 2013 Jul 2;54(7):4459-70. doi: 10.1167/iovs.12-11116.
6
EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).早期光谱域光相干断层扫描生物标志物对视神经型 2 型黄斑毛细血管扩张症对侧眼改变的确认:病例对照研究(印度黄斑毛细血管扩张症报告 1)。
Retina. 2021 Mar 1;41(3):471-479. doi: 10.1097/IAE.0000000000002954.
7
Retinal crystals in type 2 idiopathic macular telangiectasia.2 型特发性黄斑毛细血管扩张症中的视网膜晶体。
Ophthalmology. 2011 Dec;118(12):2461-7. doi: 10.1016/j.ophtha.2011.05.022. Epub 2011 Aug 12.
8
Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.2型黄斑毛细血管扩张症血管变化的进展:频域光学相干断层扫描与光学相干断层扫描血管造影的比较
Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1381-1392. doi: 10.1007/s00417-019-04323-0. Epub 2019 May 16.
9
Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.视网膜前新生血管形成:2型黄斑毛细血管扩张症中一种新型光学相干断层扫描血管造影表现
Ophthalmol Retina. 2019 Jun;3(6):516-522. doi: 10.1016/j.oret.2019.01.022. Epub 2019 Feb 6.
10
Macular ganglion cell layer imaging in preperimetric glaucoma with speckle noise-reduced spectral domain optical coherence tomography.用斑点噪声减少的谱域光学相干断层扫描技术在周边视野青光眼前期进行黄斑神经节细胞层成像。
Ophthalmology. 2011 Dec;118(12):2414-26. doi: 10.1016/j.ophtha.2011.06.015. Epub 2011 Sep 15.

本文引用的文献

1
Prevalence and Severity of Diabetic Retinopathy in Patients with Macular Telangiectasia Type 2.2 型黄斑毛细血管扩张症患者的糖尿病视网膜病变的患病率和严重程度。
Ophthalmol Retina. 2021 Oct;5(10):999-1004. doi: 10.1016/j.oret.2021.01.002. Epub 2021 Jan 12.
2
Updating the Staging System for Diabetic Retinal Disease.更新糖尿病视网膜病变分期系统。
Ophthalmology. 2021 Apr;128(4):490-493. doi: 10.1016/j.ophtha.2020.10.008. Epub 2020 Nov 17.
3
Comparison of the Iowa Reference Algorithm to the Heidelberg Spectralis optical coherence tomography segmentation algorithm.
比较爱荷华参考算法与海德堡 Spectralis 光学相干断层扫描分割算法。
J Biophotonics. 2020 May;13(5):e201960187. doi: 10.1002/jbio.201960187. Epub 2020 Feb 20.
4
Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.黄斑病变和外周神经病中的丝氨酸和脂质代谢。
N Engl J Med. 2019 Oct 10;381(15):1422-1433. doi: 10.1056/NEJMoa1815111. Epub 2019 Sep 11.
5
Diabetic Retinal Neurodegeneration-Should We Redefine Retinopathy From Diabetes?糖尿病性视网膜神经变性——我们是否应该重新定义糖尿病视网膜病变?
JAMA Ophthalmol. 2019 Oct 1;137(10):1132-1133. doi: 10.1001/jamaophthalmol.2019.2536.
6
Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.睫状神经营养因子对 2 型黄斑毛细血管扩张症患者视网膜神经退行性变的影响:一项随机临床试验。
Ophthalmology. 2019 Apr;126(4):540-549. doi: 10.1016/j.ophtha.2018.09.041. Epub 2018 Oct 4.
7
Genetic Penetrance of Macular Telangiectasia Type 2.黄斑毛细血管扩张症 2 型的遗传外显率。
JAMA Ophthalmol. 2018 Oct 1;136(10):1158-1163. doi: 10.1001/jamaophthalmol.2018.3283.
8
Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease.一种临床有用的糖尿病视网膜病变血管和神经方面综合分类方法。
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):519-527. doi: 10.1167/iovs.17-21873.
9
CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.2型黄斑毛细血管扩张症临床及结构进展与视力丧失的相关性:黄斑毛细血管扩张症项目报告第6号——黄斑毛细血管扩张症研究组
Retina. 2018 Jan;38 Suppl 1(Suppl 1):S8-S13. doi: 10.1097/IAE.0000000000001697.
10
Genome-wide analyses identify common variants associated with macular telangiectasia type 2.全基因组分析鉴定出与黄斑毛细血管扩张症 2 型相关的常见变异。
Nat Genet. 2017 Apr;49(4):559-567. doi: 10.1038/ng.3799. Epub 2017 Feb 27.